$19.19
0.673.62%
가까이에: Nov 20, 4:00 PM EST
$19.20
0.010.05%
시간외: Nov 20, 5:29 PM EST

The average analyst price target for Vor Biopharma is $61.67, 221.2% above the current price. Of 13 analysts, 11 rate it Buy and 2 Hold. Targets range from $8 to $160. The latest change came on Oct 21, 2026, when William Blair initiated coverage of Vor Biopharma with an Outperform rating.
Price Target Range — 11 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months